Carreira Delgado, Patricia Esmeralda
Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis. [artículo] - Annals of the Rheumatic Diseases, 2012 - 71(1):114-9.
Formato Vancouver:
Carmona FD, Gutala R, Simeón CP, Carreira P, Ortego-Centeno N, Vicente-Rabaneda E, et al. Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis. Ann Rheum Dis. 2012 Jan;71(1):114-9.
PMID: 21926187
Contiene 34 referencias
OBJECTIVE: Systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) are related chronic autoimmune diseases of complex aetiology in which the interferon (IFN) pathway plays a key role. Recent studies have reported an association between IRF7 and SLE which confers a risk to autoantibody production. A study was undertaken to investigate whether the IRF7 genomic region is also involved in susceptibility to SSc and the main clinical features.
Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis. [artículo] - Annals of the Rheumatic Diseases, 2012 - 71(1):114-9.
Formato Vancouver:
Carmona FD, Gutala R, Simeón CP, Carreira P, Ortego-Centeno N, Vicente-Rabaneda E, et al. Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis. Ann Rheum Dis. 2012 Jan;71(1):114-9.
PMID: 21926187
Contiene 34 referencias
OBJECTIVE: Systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) are related chronic autoimmune diseases of complex aetiology in which the interferon (IFN) pathway plays a key role. Recent studies have reported an association between IRF7 and SLE which confers a risk to autoantibody production. A study was undertaken to investigate whether the IRF7 genomic region is also involved in susceptibility to SSc and the main clinical features.
